Evidence map›Paper›PMID 31084262›Full record

ArticleEuropean journal of preventive cardiology2020

Combined effect of posttraumatic stress disorder and prescription opioid use on risk of cardiovascular disease.

Jeffrey F Scherrer, Joanne Salas, Patrick Lustman, Peter Tuerk, Sarah Gebauer, Sonya B Norman, F David Schneider, Kathleen M Chard, Carissa van den Berk-Clark, Beth E Cohen and 1 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in European journal of preventive cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

Jeffrey F ScherrerDepartment of Family and Community Medicine, Saint Louis University School of Medicine, USA.
Joanne SalasDepartment of Family and Community Medicine, Saint Louis University School of Medicine, USA.
Patrick LustmanDepartment of Psychiatry, Washington University School of Medicine, St. Louis, USA.
Peter TuerkSheila C. Johnson Center for Clinical Services, Department of Human Services, University of Virginia, Charlottesville, USA.
Sarah GebauerDepartment of Family and Community Medicine, Saint Louis University School of Medicine, USA.
Sonya B NormanNational Center for PTSD and Department of Psychiatry, University of California San Diego, USA.
F David SchneiderDepartment of Family and Community Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
Kathleen M ChardTrauma Recovery Center Cincinnati VAMC, USA.
Carissa van den Berk-ClarkDepartment of Family and Community Medicine, Saint Louis University School of Medicine, USA.
Beth E CohenDepartment of Medicine, University of California San Francisco School of Medicine, USA.
Paula P SchnurrNational Center for PTSD and Department of Psychiatry, Geisel School of Medicine at Dartmouth, USA.
Saint Louis University · USCincinnati VA Medical Center · USHarry S. Truman Memorial Veterans' Hospital · USNational Center for PTSD · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Diego · USUniversity of California, San Francisco · USUniversity of Virginia · USVA St. Louis Health Care System · US

Funding

PTSD Treatment: Effects on Health Behavior, Cardiovascular and Metabolic DiseaseR01HL125424 · NHLBI · SAINT LOUIS UNIVERSITY · PI SCHERRER, JEFFREY F. · 2016 to 2019
$2.3M
NHLBI NIH HHS R01 HL125424
6 · The paper itself

Abstract

aimPrescription opioid analgesic use (OAU) is associated with increased risk of cardiovascular disease (CVD). OAU is more common in patients with than without posttraumatic stress disorder (PTSD), and PTSD is associated with higher CVD risk. We determined whether PTSD and OAU have an additive or multiplicative association with incident CVD. METHODS AND

resultsVeterans Health Affairs patient medical record data from 2008 to 2015 was used to identify 2861 patients 30-70 years of age, free of cancer, CVD and OAU for 12 months before index date. We defined a four-level exposure variable: 1) no PTSD/no OAU, 2) OAU alone, 3) PTSD alone and 4) PTSD+OAU. Cox proportional hazard models estimated the association between the exposure variable and incident CVD. The mean age was 49.0 (±11.0), 85.7% were male and 58.3% were White, 34.4% had no PTSD/no OAU, 32.9% had PTSD alone, 10.6% had OAU alone, and 22.1% had PTSD+OAU. Compared with patients with no PTSD/no OAU, those with PTSD alone were not at increased risk of incident CVD (hazard ratio = 0.82; 95% confidence interval (CI): 0.63-1.17); however, OAU alone and PTSD+OAU were both significantly associated with incident CVD (hazard ratio = 1.99; 95% CI:1.36-2.92 and hazard ratio = 2.20; 95% CI: 1.61-3.02). There was no significant additive or multiplicative PTSD and OAU association with incident CVD.

conclusionOAU is associated with nearly a two-fold increased risk of CVD in patients with and without PTSD. Despite no additive or multiplicative interaction effects, the high prevalence of OAU in PTSD may represent a novel contributor to the elevated CVD burden among patients with PTSD.

Indexed as

VeteransAdolescentAdultAgedAnalgesics, OpioidCardiovascular DiseasesFemaleHumansIncidenceMaleMiddle AgedPrescriptionsRisk FactorsStress Disorders, Post-TraumaticUnited StatesYoung AdultAnalgesics, Opioidcardiovascular diseasecohortepidemiologymedical recordsopioidsPTSD

Identifiers

PMID31084262
PMCPMC7052811
OpenAlexW2945081171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.